158 related articles for article (PubMed ID: 2777209)
21. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
22. Adenosine receptor blockade reduces splanchnic hyperemia in cirrhotic rats.
Lee SS; Chilton EL; Pak JM
Hepatology; 1992 Jun; 15(6):1107-11. PubMed ID: 1592351
[TBL] [Abstract][Full Text] [Related]
23. Effects of calcium antagonists on hepatic and systemic hemodynamics in awake portal hypertensive rats.
Nagasawa M; Kawasaki T; Yoshimi T
J Gastroenterol; 1996 Jun; 31(3):366-72. PubMed ID: 8726828
[TBL] [Abstract][Full Text] [Related]
24. Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine.
Moreau R; Cailmail S; Lebrec D
Liver; 1994 Feb; 14(1):45-9. PubMed ID: 8177029
[TBL] [Abstract][Full Text] [Related]
25. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.
Kravetz D; Bosch J; Arderiu MT; Pizcueta MP; Casamitjana R; Rivera F; Rodés J
Am J Physiol; 1988 Mar; 254(3 Pt 1):G322-8. PubMed ID: 2894777
[TBL] [Abstract][Full Text] [Related]
26. On the pathogenesis of portal hypertension in cirrhosis of the liver.
Shibayama Y
Liver; 1988 Apr; 8(2):95-9. PubMed ID: 3367713
[TBL] [Abstract][Full Text] [Related]
27. Effect of a somatostatin analogue (SMS 201-995) on hemodynamics and glucagon secretion in cirrhotic rats.
Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
Gastroenterol Jpn; 1993 Apr; 28(2):276-83. PubMed ID: 8486215
[TBL] [Abstract][Full Text] [Related]
28. Reduction of intrahepatic vascular space in the pathogenesis of portal hypertension. In vitro and in vivo studies in the rat.
Lee SS; Hadengue A; Girod C; Braillon A; Lebrec D
Gastroenterology; 1987 Jul; 93(1):157-61. PubMed ID: 3582902
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium.
Lee SS; Girod C; Braillon A; Hadengue A; Lebrec D
Am J Physiol; 1986 Aug; 251(2 Pt 1):G176-80. PubMed ID: 3740260
[TBL] [Abstract][Full Text] [Related]
30. Alteration in response of the portal tributary vascular bed to the beta-agonist dobutamine in rats with extrahepatic portal hypertension.
Braillon A; Calès P; Girod C; Lebrec D
J Hepatol; 1986; 2(2):267-75. PubMed ID: 3958476
[TBL] [Abstract][Full Text] [Related]
31. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
Van de Casteele M; Hösli M; Sägesser H; Reichen J
J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
[TBL] [Abstract][Full Text] [Related]
32. Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites.
Roulot D; Moreau R; Gaudin C; Bacq Y; Braillon A; Hadengue A; Frohly P; Lebrec D
Gastroenterology; 1992 Apr; 102(4 Pt 1):1309-18. PubMed ID: 1551536
[TBL] [Abstract][Full Text] [Related]
33. Effect of ethanol on splanchnic hemodynamics in awake and unrestrained rats with portal hypertension.
Verma-Ansil B; Carmichael FJ; Saldivia V; Varghese G; Orrego H
Hepatology; 1989 Dec; 10(6):946-52. PubMed ID: 2583689
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration.
Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
Dig Dis Sci; 1993 Dec; 38(12):2195-202. PubMed ID: 8261820
[TBL] [Abstract][Full Text] [Related]
35. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
36. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
J Gastroenterol Hepatol; 1996 Oct; 11(10):985-92. PubMed ID: 8912139
[TBL] [Abstract][Full Text] [Related]
37. Effects of reserpine administration in two models of portal hypertension in rats.
Lin HC; Yu PC; Lee SD; Tsai YT; Kuo JS; Yang MC
J Hepatol; 1993 Nov; 19(3):413-7. PubMed ID: 8151103
[TBL] [Abstract][Full Text] [Related]
38. Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed rats.
Lin HC; Soubrane O; Lebrec D
Hepatology; 1991 Aug; 14(2):325-30. PubMed ID: 1860689
[TBL] [Abstract][Full Text] [Related]
39. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.
Oberti F; Rifflet H; Maïga MY; Pilette C; Gallois Y; Douay O; Le Jeune JJ; Saumet JL; Calès P
J Hepatol; 1997 Jan; 26(1):167-73. PubMed ID: 9148008
[TBL] [Abstract][Full Text] [Related]
40. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
